Examining Hepatitis C Reinfection Rates in Kenya
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03564639|
Recruitment Status : Not yet recruiting
First Posted : June 21, 2018
Last Update Posted : October 26, 2018
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||170 participants|
|Official Title:||Hepatitis C Reinfection in an Injection Drug Using Population in Kenya: A Follow-up to the TLC-IDU Hepatitis C V Supplement Study.|
|Estimated Study Start Date :||November 2018|
|Estimated Primary Completion Date :||September 2019|
|Estimated Study Completion Date :||September 2019|
Injection drug users with HCV
People who inject drugs who were confirmed positive for HCV and initiated treatment in the parent study beginning in September 2017.
- HCV Reinfection [ Time Frame: 6-18 months post sustained virologic response (SVR) to HCV treatment. ]The reinfection of patients with hepatitis C after completion of a previous HCV infection treatment.
- Evaluate psychoeducational counseling [ Time Frame: 6 months ]Brief questionnaire on knowledge, attitude and beliefs of each participant.
- Examine usage of methadone maintenance [ Time Frame: 12 months ]Brief questionnaire on services used
- Examine usage of needle exchange programs [ Time Frame: 12 months ]Brief questionnaire on services used
- Evaluate psychoeducational counseling [ Time Frame: 12 months ]Brief questionnaire on knowledge, attitude and beliefs of each participant.
- HCV reinfection referrals for treatment at Kenyetta National Hospital [ Time Frame: 9-16 months post treatment ]Confirmed HCV reinfection cases will receive referrals to Kenyatta National Hospital and Coast General Hospital for treatment and management.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03564639
|Contact: Abbe Mulleremail@example.com|
|Contact: Ann Kurth, p||203-785-2393|
|Principal Investigator:||Ann Kurth, PhD||Yale University School of Nursing|